Registered 15. aprill 2005, primary activity: Research and experimental development on natural sciences and engineering. Main place of business in Õssu küla, Kambja vald, Tartu maakond.
Current debt: 0,00 €. History updated daily.
| Year | Revenue | Profit | Equity | Assets | Employees | ||
|---|---|---|---|---|---|---|---|
| 2024AUD | 12 916 070 € | 848 033 € | 18,5m € | 30,6m € | 167 | 27.06.2025 | |
| 2023AUD | 13 347 905 € | 2 475 854 € | 17,7m € | 23,7m € | 134 | 11.06.2024 | |
| 2022AUD | 13 677 072 € | 5 967 760 € | 15,2m € | 19,6m € | 102 | 11.05.2023 | |
| Year | Revenue (a) | State taxes | Taxes on workforce | Employees (Q4) |
|---|---|---|---|---|
| 2026I Q | 4 171 962 € | 841 560 € | 911 298 € | 185 |
| 2025 | 13 573 665 € | 3 576 258 € | 3 853 800 € | 180 |
| 2024 | 19 177 606 € | 2 923 033 € | 3 115 131 € | 184 |
| 2023 | 22 620 954 € | 2 302 179 € | 2 366 889 € | 157 |
| 2022 | 16 859 839 € |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| Revenue 2026 | 4,2m € | – | – | – |
| State taxes 2026 | 842k € | – | – | – |
| Taxes on workforce 2026 | 911k € | – | – | – |
| Employees 2026 | 185 | – | – | – |
| Revenue 2025 | 4,6m € | 3,1m € | 3,0m € | 2,9m € |
| State taxes 2025 | 968k € | 877k € |
2026: 723k € · 2025: 6,2m € · 2024: 6,1m €
Icosagen Cell Factory OÜ is connected to 6 other companies through 2 people who hold a role here and elsewhere. The strongest tie runs through Mart Ustav (4 companies).
| Company | Role | Reg. code |
|---|---|---|
| Amplikon OÜ | Board memberFounderUltimate beneficial ownerShareholder 100% | 12860392 |
| ICO Park OÜ | Ultimate beneficial owner |
| 2021AUD |
| 11 485 743 € |
| 5 332 983 € |
| 9,2m € |
| 11,7m € |
| 67 |
| 17.06.2022 |
| 2020AUD | 6 679 291 € | 1 743 876 € | 3,9m € | 5,8m € | 50 | 29.06.2021 |
| 2019AUD | 4 767 928 € | 704 429 € | 2,1m € | 3,8m € | 44 | 16.06.2020 |
| 1 530 654 € |
| 1 577 439 € |
| 119 |
| 879k € |
| 853k € |
| Taxes on workforce 2025 | 1,0m € | 946k € | 948k € | 920k € |
| Employees 2025 | 190 | 184 | 183 | 180 |
| Revenue 2024 | 5,9m € | 5,1m € | 3,6m € | 4,5m € |
| State taxes 2024 | 801k € | 680k € | 747k € | 695k € |
| Taxes on workforce 2024 | 852k € | 727k € | 792k € | 744k € |
| Employees 2024 | 170 | 170 | 175 | 184 |
| Revenue 2023 | 5,6m € | 4,7m € | 4,8m € | 7,6m € |
| State taxes 2023 | 604k € | 577k € | 552k € | 569k € |
| Taxes on workforce 2023 | 641k € | 538k € | 588k € | 599k € |
| Employees 2023 | 134 | 140 | 148 | 157 |
| Revenue 2022 | 4,9m € | 3,9m € | 3,9m € | 4,1m € |
| State taxes 2022 | 366k € | 374k € | 391k € | 400k € |
| Taxes on workforce 2022 | 390k € | 350k € | 414k € | 424k € |
| Employees 2022 | 94 | 108 | 116 | 119 |
| 12401945 |
| Icosagen AS | FounderUltimate beneficial ownerBoard member | 10565884 |
| Sihtasutus Geenikeskus | Founder | 90001569 |
| Company | Role | Reg. code |
|---|---|---|
| BioBalt Holding OÜ | Shareholder 13% | 11393103 |
| Icosagen AS | Supervisory board memberUltimate beneficial owner | 10565884 |